Encompass Health director awarded 85 RSUs

Encompass Health Corp director Leslye G. Katz received an equity award tied to a dividend reinvestment feature.

Rhea-AI Filing Summary

Encompass Health Corp director Leslye G. Katz received an equity award tied to a dividend reinvestment feature. On April 15, 2026, she acquired 85 restricted stock units (RSUs) for Encompass Health common stock at no cost, credited in connection with a $0.19 per share dividend and a $105.24 closing price. Following this routine compensation-related award, she directly holds 47,924 shares of Encompass Health common stock.

Insider Trade Summary

Grant/Award: 85 shares

Grant/Award 1 txn

Insider KATZ LESLYE G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	85	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 47,924 shares (Direct)

Footnotes (1)

1. F1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Key Figures

RSUs awarded: 85 units Dividend per share: $0.19 Closing stock price: $105.24 +2 more

5 metrics

RSUs awarded 85 units Dividend-related RSU award on April 15, 2026

Dividend per share $0.19 Common stock dividend paid April 15, 2026

Closing stock price $105.24 Used to calculate RSUs on dividend payment date

Shares held after transaction 47,924 shares Encompass Health common stock directly owned after RSU award

Award price per unit $0.00 Grant/award acquisition of RSUs, no cash paid by director

Key Terms

restricted stock units, non-employee director, dividend, restricted stock unit award agreements

4 terms

restricted stock units financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-employee director financial

"RSUs are credited to each non-employee director's account in connection with common stock dividend payments"

dividend financial

"in connection with common stock dividend payments, The number of RSUs credited is equal to"

A dividend is a payment that a company gives to its shareholders, usually from its profits. It’s like a bonus or reward for owning the company's stock, and it can provide a steady income stream for investors. Companies pay dividends to share their success with the people who own their stock.

restricted stock unit award agreements financial

"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) report for Leslye G. Katz?

Encompass Health reported that director Leslye G. Katz received 85 restricted stock units as an equity award. These RSUs were credited automatically under existing award agreements in connection with a common stock dividend paid on April 15, 2026.

Why did Leslye G. Katz receive 85 RSUs from Encompass Health (EHC)?

She received 85 RSUs because Encompass Health credits additional restricted stock units to non-employee directors when common stock dividends are paid. The number of RSUs is based on existing RSU holdings, the $0.19 dividend, and the $105.24 closing stock price.

Did Leslye G. Katz buy or sell Encompass Health (EHC) shares in this Form 4?

She did not buy or sell shares on the market. The Form 4 shows a grant or award acquisition of 85 RSUs at a price of $0.00 per unit, reflecting a compensation-related credit linked to a dividend payment, not an open-market trade.

How many Encompass Health (EHC) shares does Leslye G. Katz own after this RSU award?

After the reported RSU award, Leslye G. Katz directly owns 47,924 shares of Encompass Health common stock. This figure reflects her position following the April 15, 2026 dividend-related RSU credit reported in the Form 4 filing.

How were the 85 RSUs for Encompass Health (EHC) calculated for Leslye G. Katz?

The RSUs were calculated by multiplying her RSUs outstanding on the dividend record date by the $0.19 per share dividend, then dividing by the $105.24 closing price on the dividend payment date. This formula comes from her outstanding restricted stock unit award agreements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 02:45 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KATZ LESLYE G

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	04/15/2026		A		85(1)	A	$0	47,924	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Leslye G. Katz	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)